Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism.
From the Departments of Pathology and Molecular Medicine, Medicine, and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada (M.A.C.); and the Departments of Medicine and Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.C.).
Mark A
MA
Crowther
From the Departments of Pathology and Molecular Medicine, Medicine, and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada (M.A.C.); and the Departments of Medicine and Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.C.).
Adam
A
Cuker
D000925:Anticoagulants; D006801:Humans; D009025:Morpholines; D000069552:Rivaroxaban; D013876:Thiophenes; D014680:Veins; D054556:Venous Thromboembolism
D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban